Pharmaceutical Contract Packaging Market Recent Developments

Pharmaceutical Contract Packaging Market Projected Growth and Trends

The global pharmaceutical contract packaging market is expected to grow significantly, rising from USD 17.06 billion in 2024 to around USD 43.46 billion by 2034. This growth is projected to occur at a compound annual growth rate (CAGR) of 9.8% over the next decade.

Download Statistical Data: https://www.towardspackaging.com/download-statistics/5165

Trends in the Pharmaceutical Contract Packaging Market

• Growing Demand for Sustainable Packaging
  Consumers and companies alike are increasingly prioritizing eco-friendly and sustainable packaging. The shift toward using recyclable materials and green technologies is in line with global environmental goals and the rising demand for more sustainable options.
• Rising Trend of Outsourcing
  Pharmaceutical companies are increasingly turning to outsourcing for packaging services. This trend is driven by the need to reduce costs, focus on their core activities, and access specialized packaging expertise that enhances efficiency.
• Growth of Biopharmaceuticals
  With the growing demand for biopharmaceuticals, there is an increased need for specialized packaging solutions. This includes packaging for biologic products, which often require temperature control and customized delivery systems to maintain their effectiveness.
• Industry Consolidation
  The pharmaceutical contract packaging sector is seeing consolidation, with larger companies acquiring smaller ones. This strategy helps them expand their services, capabilities, and global reach to better meet the growing demand.
• Focus on Customization
  Pharmaceutical companies are looking for more personalized and customized packaging options that align with their brand identity and meet specific consumer preferences. This has led to innovation in packaging designs and materials, offering unique solutions for different market needs.

Latest Announcements from Industry Leaders

Stevanato Group S.p.A. (NYSE: STVN), SCHOTT Pharma AG & Co. KGaA (MDAX: 1SXP), and Gerresheimer AG, three major players in the pharmaceutical, biotech, and cosmetic industries, have teamed up to form the “Alliance for RTU” (Ready-to-Use). This strategic partnership aims to promote the adoption of ready-to-use (RT) vials and cartridges in the market. By highlighting the advantages of RT designs over traditional bulk packaging, the alliance will share technical knowledge and expertise in high-quality sterile primary packaging, particularly for ready-to-fill vials and cartridges, with pharmaceutical companies, contract manufacturing organizations (CMOs), and contract development and manufacturing organizations (CDMOs).

Lukas Burkhardt from Gerresheimer AG emphasized that the company is fully ready for the shift to RT vials and cartridges, noting that recent advancements have made RT processing a mature technology that will enhance customer efficiency, reduce costs, and speed up time to market. Franco Stevanato, CEO of Stevanato Group, added that RT vials and cartridges have significantly improved product quality, making pharmaceutical procedures more reliable and efficient. This partnership will help elevate industry standards, ensuring patients worldwide receive safer and more effective medications.

Andreas Reisse, CEO of SCHOTT Pharma, highlighted that the industry’s move towards ready-to-use vials and cartridges is part of a broader shift aimed at improving efficiency and quality in aseptic filling processes. This collaboration will increase production capacity to meet the growing demand for these solutions, which help reduce complexity and meet the stringent requirements of modern pharmaceutical production. The alliance will be officially launched at a special event at the PHI in Milan on October 8, 2024.

Recent Developments in Pharmaceutical Contract Packaging

In March 2024, Adare Pharma Solutions, a contract development and manufacturing organization (CDMO) specializing in oral dosage forms, announced an expansion of its warehousing and packaging capabilities in Milan, Italy. The company added a new two-story, 2,800-square-meter facility, which will house an advanced packaging plant designed specifically for tablet and capsule packaging. The new site will utilize the Marchesini Integra 220S MA260 packaging system to produce Aclar, Triplex, PVC, PVDC, and ALU/ALU blisters, with a capacity to package over 50 million blisters annually. The system also includes Robocombi “pick and place” and serialization features. The new packaging line is expected to be operational by the fourth quarter of 2024, and the expansion also includes a second packaging line and an additional 1,000 square meters of storage space with a 900-pallet capacity

Buy Premium Global Insight: https://www.towardspackaging.com/price/5165

Get the latest insights on packaging industry segmentation with our Annual Membership – https://www.towardspackaging.com/get-an-annual-membership

If you have any questions, please feel free to contact us at sales@towardspackaging.com

Browse our Brand-New Journal:

https://www.towardshealthcare.com

https://www.towardsautomotive.com

For Latest Update Follow Us: https://www.linkedin.com/company/towards-packaging/

Get Our Freshly Printed Chronicle: https://www.packagingwebwire.com/